sars cov 2 — grants

Sort

8,912 grants matching “sars cov 2”

Orbitrap Exploris 480 Mass Spectrometer for Biomedical Research

$881,950

Susan T Weintraub · University Of Texas Hlth Science Center · S10 · FY2022 · OD

Project 1: Definition of the structural principles underlying broadly protective humoral immunity to coronaviruses

$881,853

David Veesler · University Of Washington · P01 · FY2022 · AI

Structural and Social Determinants of Maternal Mental Health, Morbidity, and Inequities in COMBO

$881,466

Dani Dumitriu · Columbia University Health Sciences · R01 · FY2021 · MH

Experimental Pathology Laboratory (EPL)

$879,776

Stephen Hewitt · Division Of Basic Sciences - Nci · ZIC · FY2024 · CA

Task B08: Development and Use of a Non-Human Primate Model of SARS-CoV-2 Infection

$879,721

Karen Thompson · Battelle Centers/Pub Hlth Res & Evaluatn · N01 · FY2021 · AI

Diagnosis of MIS-C in febrile children

$879,259

Audrey Ragan Odom John · Children'S Hosp Of Philadelphia · R61 · FY2021 · HD

Multi-parametric Integrated Molecular Detection of SARS-CoV-2 from Biofluids by Adapting Single Extracellular Vesicle Characterization Technologies

$878,950

Eduardo Reategui · Ohio State University · U18 · FY2022 · TR

The generation and protective function of lung tissue resident memory T cells following SARS-CoV-2 infection or vaccination

$878,617

John Ross Teijaro · Scripps Research Institute, The · R01 · FY2023 · AI

Project 2: Susceptibility of Lung Cancer Cells to SARS- CoV-2 Infection and Antibody-Mediated Neutralization

$878,495

Adolfo Garcia-Sastre · Icahn School Of Medicine At Mount Sinai · U54 · FY2020 · CA

Identifying biomarker signatures of prognostic value for Multisystem Inflammatory Syndrome in Children (MIS-C)

$877,921

Juan C Salazar · Connecticut Children'S Medical Center · R61 · FY2021 · HD

RNA: New Antimicrobial Strategies

$877,860

Adrian Ferrã-D'amarã · National Heart, Lung, And Blood Institute · ZIA · FY2022 · HL

Longitudinal At Home Smell Testing to Detect Infection by SARS-CoV-2

$877,287

Mark W Albers · Massachusetts General Hospital · U01 · FY2021 · DC

Serologic and Molecular Studies of human anti-hCoV antibody cross-immunity and protective responses among endemic HCoVs and SARS-CoV2

$876,907

Wayne A. Marasco · Dana-Farber Cancer Inst · R01 · FY2022 · AI

Systems Biology Approaches to Viral Pathogenesis and Immunity

$875,992

Michael G Katze · Oregon Health & Science University · U54 · FY2013 · AI

Serologic and Molecular Studies of human anti-hCoV antibody cross-immunity and protective responses among endemic HCoVs and SARS-CoV2

$874,734

Wayne A. Marasco · Dana-Farber Cancer Inst · R01 · FY2023 · AI

HIV mRNA vaccine strategies for efficient priming, diversity and durability of immune responses

$874,358

Parham Ramezani-Rad · La Jolla Institute For Immunology · R61 · FY2025 · AI

A Multi-Dimensional Linked Registry to Identify Biological, Clinical, Health System, and Socioeconomic Risk Factors for COVID-19-Related Cardiovascular Events

$873,210

Robert Yeh · Beth Israel Deaconess Medical Center · R01 · FY2021 · HL

Immune Responses to Malaria, HIV and SARS-CoV-2 Infection and Immunization - Service Core

$871,800

Peter Skene · Seattle Children'S Hospital · U19 · FY2024 · AI

Microbial Impact on NeuroDegeneration in Alzheimer's Dementia: MIND-AD

$871,255

Adam Peter Spira · Johns Hopkins University · R01 · FY2022 · AG

Diagnosis of MIS-C in febrile children

$871,132

Audrey Ragan Odom John · Children'S Hosp Of Philadelphia · R61 · FY2022 · HD

An OpenData Portal to share SARS-CoV-2 drug repurposing data in real time

$870,948

Matthew Hall · National Center For Advancing Translational Sciences · ZIA · FY2024 · TR

Orbitrap Exploris 480 Mass Spectrometer for Biomedical Research

Project 1: Definition of the structural principles underlying broadly protective humoral immunity to coronaviruses

Structural and Social Determinants of Maternal Mental Health, Morbidity, and Inequities in COMBO

Experimental Pathology Laboratory (EPL)

Task B08: Development and Use of a Non-Human Primate Model of SARS-CoV-2 Infection

Diagnosis of MIS-C in febrile children

Multi-parametric Integrated Molecular Detection of SARS-CoV-2 from Biofluids by Adapting Single Extracellular Vesicle Characterization Technologies

The generation and protective function of lung tissue resident memory T cells following SARS-CoV-2 infection or vaccination

Project 2: Susceptibility of Lung Cancer Cells to SARS- CoV-2 Infection and Antibody-Mediated Neutralization

Identifying biomarker signatures of prognostic value for Multisystem Inflammatory Syndrome in Children (MIS-C)

RNA: New Antimicrobial Strategies

Longitudinal At Home Smell Testing to Detect Infection by SARS-CoV-2

Serologic and Molecular Studies of human anti-hCoV antibody cross-immunity and protective responses among endemic HCoVs and SARS-CoV2

Systems Biology Approaches to Viral Pathogenesis and Immunity

Serologic and Molecular Studies of human anti-hCoV antibody cross-immunity and protective responses among endemic HCoVs and SARS-CoV2

HIV mRNA vaccine strategies for efficient priming, diversity and durability of immune responses

Structural and Functional Characterization of SARS-CoV-2 RNA Processing Factors

Project-002

COVID-19 Sample Collection and Vaccine Studies

High-Throughput Molecular Profiling Core

A Multi-Dimensional Linked Registry to Identify Biological, Clinical, Health System, and Socioeconomic Risk Factors for COVID-19-Related Cardiovascular Events

Immune Responses to Malaria, HIV and SARS-CoV-2 Infection and Immunization - Service Core

Microbial Impact on NeuroDegeneration in Alzheimer's Dementia: MIND-AD

Diagnosis of MIS-C in febrile children

An OpenData Portal to share SARS-CoV-2 drug repurposing data in real time